“We are campaigning for greater choice for patients on warfarin about how their condition should be managed. Our goal is to empower patients and we believe where possible they should have the choice about whether to self-test or self-manage their treatment. We believe that this change would enable improved health outcomes and save time and money for both patients and the NHS.”
There are more than 1.2 million people in the UK on warfarin of which less than two per cent benefit from self-monitoring, despite evidence that it can cut the risk of death by nearly two-fifths and more than halve the risk of strokes. AntiCoagulation Self-Monitoring Alliance (ACSMA) launched in October 2012 with the specific objective of achieving greater access via prescription to INR self-monitoring technology for people receiving warfarin therapy. ACSMA is also seeking to raise awareness of the benefits of self-monitoring and aims to ensure that people are equipped to have informed discussions with their healthcare professionals on this topic.
- To ensure INR self-monitoring technology is available, accessible and on prescription through the NHS for eligible patients
- Increase awareness of the benefits of INR self-monitoring
- To ensure those taking long term warfarin are able to have an informed discussion with their doctor about self-monitoring
ACSMA comprises four of the UK’s leading charities and patient groups – AntiCoagulation Europe; the Children’s Heart Federation; AF Association; Mechanical Heart Valve Support Group – that exist to provide advice, support and guidance to people on oral anticoagulation therapy, as well as their families and healthcare professionals. Healthcare company Roche is also part of the alliance.
About AntiCoagulation Europe (ACE)
AntiCoagulation Europe (ACE) is a registered charity committed to the prevention of thrombosis and the provision of inf0ormation and support for people receiving anticoagulant and antiplatelet therapy. For more information, please go to the website: www.anticoagulationeurope.org/
About AF Association
AF Association is an international charity which provides information, support and access to established, new or innovative treatments for Atrial Fibrillation (AF). For more information, please go to the website:www.atrialfibrillation.org.uk/
About Children’s Heart Federation
Children’s Heart Federation (CHF) is the UK’s leading children’s heart charity and an umbrella organisation for 23 member groups which support heart children and their families. CHF supports families through its information service, grants programme, peer support events and the provision of medical equipment. The charity also lobbies for changes to the health, social care and education systems for the benefit of heart families. For more information, please go to the website: www.chfed.org.uk/
About Mechanical Heart Valve Support Group (MHV)
Mechanical Heart Valve Support Group (MHV) is a ‘not for profit’ online volunteer support group for people and their families with mechanical heart valves which necessitate anticoagulant therapy for life. Over 5000 MHVs are implanted in the UK every year. For more information please go to the website www.MechanicalHeartValve.org/
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2011, Roche had over 80,000 employees worldwide and invested over 8 billion Swiss francs in R&D. The Group posted sales of 42.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information visit: www.roche.com and www.roche.co.uk